Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Putting prevention in their pockets

23.08.2016

UB-developed smartphone app may help improve antiretroviral therapy adherence among people living with HIV

Would people living with HIV be willing to self-report on daily substance use and antiretroviral therapy (ART) adherence using a smartphone app?


This is a screen shot of DRUM app question asking participants whether they took their medication. The app was developed and tested by researchers at the University at Buffalo.

Credit: University at Buffalo

That was a question researchers from the University at Buffalo set out to answer in a recent study. They were pleased to find that participants not only found the app easy and convenient to use -- they were also willing to provide honest responses.

"Reporting was actually high - we had 95 percent compliance with daily report completion. A key finding of our study was the ability for people living with HIV to feel comfortable reporting on sensitive health behaviors," said Sarahmona Przybyla, the study's lead author and clinical assistant professor of community health and health behavior in UB's School of Public Health and Health Professions.

A willingness to report the use of alcohol or drugs was significant because substance use is one of the most reliable predictors of poor adherence to ART, the researchers note.

Their findings, published this month in the journal AIDS Research and Treatment, were more surprising considering that the majority of the 26 study participants had never used a smartphone before. After some initial smartphone training from research staff, they completed their reports with ease.

Participants were recruited from two Buffalo-area clinics and were asked to use the app -- named Daily Reports of Using Medications, or DRUM -- to complete their reports, which took three to five minutes, between 4 p.m. and 6 p.m. each day for two weeks.

Every afternoon, the 26 study participants received a text message reminder asking them to fill out their report. If they missed that day's report, they were given the option to do a make-up when they logged into the app the next day.

Researchers were deliberate in their wording of the questions. "People living with HIV continue to be a stigmatized population, so we didn't want any of the questions we developed to draw attention to their disease. We never used 'HIV' or 'ART' - anything that would inadvertently out someone as having HIV," Przybyla said.

A sample medication question was, "Did you take your first dose?" A change in daily routine was the most commonly reported reason participants didn't take their medication, followed by simply forgetting. Use of alcohol or drugs was the third most common reason.

Participants who confirmed they had used alcohol or drugs in the past 24 hours were given a series of follow-up questions that asked why they used the substance and where they were when they used it, with a dropdown menu of answer choices.

Each participant was provided with a five-digit passcode to access the app, ensuring privacy and confidentiality. Data from the completed reports was sent in real time directly to UB's Research Institute on Addictions, which helped develop the app along with Przybyla.

In the future, the app could aid in users' decision to use alcohol since some participants in this study reported that it helped them understand exactly how much they were drinking.

And it helped users establish a pattern. "I think the surprising thing is how much the app and the text reminders helped the participants to develop a routine," said Rebecca Eliseo-Arras, a study co-author and senior research analyst at UB's Research Institute on Addictions. "For instance, some reported that the text message reminded them to do the report, but the report actually made them think about whether or not they took their medication and, if they didn't, that it prompted them to go take their medications."

Participants completed 347 out of 364 possible daily reports over the two-week span. They reported drinking alcohol on 51.6 percent and marijuana use on 35.4 percent of reporting days.

In follow-up interviews after the two weeks, researchers asked study members about their experience using the app. "Many said it was a piece of cake and that they actually looked forward to doing their daily reports," Przybyla said. "We also asked people where they were when they completed their reports. A lot of them said they were out and about. They never felt like they had to go hide in a bathroom to fill out the survey each day."

Przybyla said it's important to note that the average time since diagnosis among study participants was 17 years and that many of their friends and relatives were likely aware they had HIV. As a result, participants probably felt more comfortable completing the reports around others than someone who was more recently diagnosed and may not have been open about disclosing their disease status to others.

Three-quarters of the sample was male, and slightly more than half were African American. The average age was 48.

The app could help lead to quicker intervention in cases where a patient has missed a number of doses.

"Life expectancy has changed dramatically as a result of advances in pharmacotherapy, which is wonderful, but adherence is key. You can live a long, healthy life with HIV, but you have to take your meds," said Przybyla, who is interested in studying the role mobile technology can play in understanding health behaviors.

"Now that we have this data, we can reach out to people with HIV and say, 'We've noticed you've been using substances and that seems to be related to the fact that you've missed your doses -- what can we do to help you?' It's putting prevention in their pockets."

Media Contact

David Hill
davidhil@buffalo.edu
716-645-4651

 @UBNewsSource

http://www.buffalo.edu 

David Hill | EurekAlert!

More articles from Health and Medicine:

nachricht Spanish scientists create a 3-D bioprinter to print human skin
24.01.2017 | Carlos III University of Madrid

nachricht Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>